Global Conjugate Vaccine Market Size & Outlook, 2023-2030
The conjugate vaccine industry worldwide is expected to reach a projected revenue of US$ 35,644.7 million by 2030. A compound annual growth rate of 9.4% is expected of the worldwide conjugate vaccine industry from 2024 to 2030.
Revenue, 2023 (US$M)
$19,012.1
Forecast, 2030 (US$M)
$35,644.7
CAGR, 2024 - 2030
9.4%
Report Coverage
Worldwide
Global conjugate vaccine market, 2018-2030 (US$M)
Global conjugate vaccine market highlights
- The global conjugate vaccine market generated a revenue of USD 19,012.1 million in 2023 and is expected to reach USD 35,644.7 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 9.4% by 2030.
- In terms of segment, monovalent conjugate vaccine accounted for a revenue of USD 19,012.1 million in 2023.
- Monovalent Conjugate Vaccine is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
Global data book summary
| Market revenue in 2023 | USD 19,012.1 million |
| Market revenue in 2030 | USD 35,644.7 million |
| Growth rate | 9.4% (CAGR from 2023 to 2030) |
| Largest segment | Monovalent conjugate vaccine |
| Fastest growing segment | Monovalent Conjugate Vaccine |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Monovalent Conjugate Vaccine |
Other key industry trends
- In terms of revenue, the North America accounted for 37.7% of the global conjugate vaccine market in 2023.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Conjugate Vaccine Market Scope
Conjugate vaccine market segmentation & scope
Brand
Prevnar
Synflorix
PedvaxHIB
Hiberix
ACT-HIB
Pentacel
Menveo
Menactra
MenQuadfi
VAXNEUVANCE
CAPVAXIVE
Others
Disease
Pneumococcal
Influenza
DTP
Meningococcal
Typhoid
Pathogen
Bacterial
Viral
Combination
Patient
Pediatric
Adults
Countries
U.S.
Canada
Mexico
Japan
China
India
Australia
South Korea
Thailand
Brazil
Argentina
South Africa
Saudi Arabia
UAE
Kuwait
Conjugate Vaccine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global conjugate vaccine market size, by regions, 2018-2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
